Ventas (VTR) Could Be a Great Choice
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Ventas (VTR) have what it takes?
Ventas: Guidance Increased As Occupancy Continues To Improve
Ventas is a healthcare REIT focused on senior housing, outpatient medical & research, and triple net properties. The company increased its FFO guidance as senior housing continues to benefit from higher occupancy and improved margins. Indeed, I estimate that Ventas may see a NOI boost as high as $190 million should robust senior housing performance continue.
Are You Looking for a High-Growth Dividend Stock?
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Ventas (VTR) have what it takes?
Ventas, Inc. (VTR) CEO Debra A. Cafaro Hosts Nareit REITweek: 2025 Investor Conference (Transcript)
Ventas, Inc. (NYSE:VTR ) Bank of America Global Technology Conference June 3, 2025 1:45 PM ET Company Participants Debra A. Cafaro - Chairman & CEO J.
Ventas Issues Business Update, Raises 2025 Normalized FFO Guidance
VTR provides a business update that highlights delivering profitable growth in senior housing. It also increased the 2025 normalized FFO per share guidance.
Why Ventas (VTR) is a Great Dividend Stock Right Now
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Ventas (VTR) have what it takes?
Key Reasons to Add Ventas Stock to Your Portfolio Right Now
VTR is likely to gain from rising healthcare expenditures among senior citizens. Accretive investments in the research portfolio and solid balance sheet bode well.
Why Ventas (VTR) is a Top Dividend Stock for Your Portfolio
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Ventas (VTR) have what it takes?
Ventas, Inc. (VTR) Q1 2025 Earnings Call Transcript
Ventas, Inc. (NYSE:VTR ) Q1 2025 Earnings Conference Call May 1, 2025 10:00 AM ET Company Participants Bill Grant - SVP, IR Debra Cafaro - Chairman & CEO Justin Hutchens - EVP, Senior Housing & Chief Investment Officer Bob Probst - EVP & CFO Conference Call Participants James Cameron - Evercore John Kilichowski - Wells Fargo Michael Carroll - RBC Capital Markets Vikram Malhotra - Mizuho Jeff Spector - Bank of America Richard Anderson - Wedbush Omotayo Okusanya - Deutsche Bank Juan Santabria - BMO Capital Markets Seth Bersery - Citi Austin Wurschmidt - KeyBanc Capital Markets Michael Stroyak - Green Street Ron Camden - Morgan Stanley Nick Yulico - Scotiabank Mason Guel - Baird Operator Thank you for standing by. My name is Annie, and I will be your conference operator today.
Ventas Q1 FFO and Revenues Top Estimates, Same-Store Cash NOI Rises
VTR's Q1 results reflect higher same-store cash NOI due to SHOP same-store average occupancy growth.
Ventas (VTR) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Ventas (VTR) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Ventas (VTR) Beats Q1 FFO and Revenue Estimates
Ventas (VTR) came out with quarterly funds from operations (FFO) of $0.84 per share, beating the Zacks Consensus Estimate of $0.82 per share. This compares to FFO of $0.78 per share a year ago.
